Jump to section
To create evidence-backed digital treatments to help people with chronic conditions live their best lives.
Too many people feel frustrated by their lack of options for managing chronic health issues. Swing is working to offer people new ways to improve the management of fibromyalgia, autoimmune and chronic pain conditions with products they can use from the comfort of their home through.
The team at Swing have expertise in behavioral therapy, healthcare, and software, and are developing cutting-edge, accessible digital therapies using this knowledge. With a pivotal focus on scientific rigor, the company is working towards its goal to help patients digitally access cognitive behavioral therapy (CBT)-based treatments, including acceptance and commitment therapy.
The results of Swing's initial studies are encouraging. Going forward, with the support of the FDA as well as a recent funding boost, the company will be optimizing its product as it advances through the next stage: clinical trials. This process will bring Swing closer to providing therapies for people with chronic illnesses.
Steph
Company Specialist at Welcome to the Jungle
Aug 2022
$9.3m
EARLY VC
Jun 2022
$10.3m
SERIES A
This company has top investors
Mike Rosenbluth
(CEO)Previously an Engagement Manager at McKinsey & Company and VP, Strategy and Business Development at Veracyte.